EUVIMEDEUVIMED entdecken
Crossref

A Robust Chromatographic Method for Drug Release profiling of liposomal doxorubicin HCl

Isabelle I Niyonshuti, Savithra Jayaraj, Wenlei Jiang, Thilak Mudalige

Journal of Pharmaceutical Sciences · 2024

DOI: 10.1016/j.xphs.2024.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2024. Verfasst von Isabelle I Niyonshuti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Arkansas Laboratory, Office of Regulatory Affairs, Office of Regulatory Science, U.S Food and Drug Administration, Jefferson, AR 72079, United States. Hauptthemen laut MEDLINE: Doxorubicin, Drug Liberation, Polyethylene Glycols. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Oklahoma Restaurant Association, U.S. Food and Drug Administration, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomes are excellent drug delivery vehicles for chemotherapeutics as they may change the pharmacokinetics of therapeutic compounds, resulting in altered tissues distribution, and in some cases, reduced cytotoxicity and enhanced distribution and efficacy of the active pharmaceutical ingredient (API) at target tissues. Drug release profiles of liposomal formulations are crucial to support equivalence evaluation and quality control in pre- and post-approval stages. We developed an automated chromatographic method for quantifying the drug release profile of liposomal formulations containing doxorubicin to overcome the shortcomings of currently available methods. The newly developed method employs nanoparticle exclusion chromatography (nPEC), using a monolithic silica column coated with polyvinylpyrrolidone to separate the released drug from liposomal encapsulated drug. We evaluated the effects of pH, temperature, and ammonium formate concentration on the drug release rate. The optimized release buffer consisting of 5 % sucrose, 20 mM l-histidine, and 200 mM ammonium formate was selected for the drug release profiling of five liposomal formulations at 47 °C. The drug release profiles of five liposomal doxorubicin formulations were similar. Our automated method requires very small amounts of the sample and provides release profiles with high sensitivity and accuracy. In addition, this method can be applied to other liposomal products to allow for simple, fast, and accurate analysis of in vitro drug release profiling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDrug LiberationPolyethylene GlycolsAntibiotics, AntineoplasticHydrogen-Ion ConcentrationLiposomesNanoparticlesTemperatureChemistry, Pharmaceutical

Stichwörter der Autor:innen

Drug release profilingLiposomal doxorubicin HCLNanoparticle exclusion chromatography

Substanzen

DoxorubicinPolyethylene Glycolsliposomal doxorubicinAntibiotics, AntineoplasticLiposomes

Autor:innen und Institutionen

  • Arkansas Laboratory, Office of Regulatory Affairs, Office of Regulatory Science, U.S Food and Drug Administration, Jefferson, AR 72079, United States.
  • Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD 20993, United States. Electronic address: Wenlei.Jiang@fda.hhs.gov.
  • Arkansas Laboratory, Office of Regulatory Affairs, Office of Regulatory Science, U.S Food and Drug Administration, Jefferson, AR 72079, United States. Electronic address: Thilak.Mudalige@fda.hhs.gov.

Förderung

  • Oklahoma Restaurant Association
  • U.S. Food and Drug Administration
  • U.S. Department of Health and Human Services
  • Center for Drug Evaluation and Research
  • Oak Ridge Institute for Science and Education
  • U.S. Department of Energy

Zitieren

APA

Niyonshuti, I. I., Jayaraj, S., Jiang, W., & Mudalige, T. (2024). A Robust Chromatographic Method for Drug Release profiling of liposomal doxorubicin HCl. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2024.06.005

Vancouver

Niyonshuti II, Jayaraj S, Jiang W, Mudalige T. A Robust Chromatographic Method for Drug Release profiling of liposomal doxorubicin HCl. Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.xphs.2024.06.005

BibTeX
@article{Niyonshuti2024,
  author = {Niyonshuti, Isabelle I and Jayaraj, Savithra and Jiang, Wenlei and Mudalige, Thilak},
  title = {A Robust Chromatographic Method for Drug Release profiling of liposomal doxorubicin HCl},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1016/j.xphs.2024.06.005}
}
Kostenlos starten →